{
    "nct_id": "NCT05223322",
    "official_title": "DECODE Heartland: Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction",
    "inclusion_criteria": "* Adult (â‰¥ 18 years) assigned female sex at birth\n* Diagnosed with invasive non-metastatic breast cancer\n* Receiving neo-adjuvant CTx (or adjuvant CTx and undergoing breast conserving surgery) that includes anthracyclines (such as DOX) and/or targeted anti-Her2 therapy\n* Able to safely participate in moderate exercise and strength training based on MD approval\n* Willing to complete all study activities\n* Self-identifies as Black/African American or non-Hispanic White\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 100 Years",
    "exclusion_criteria": "* Unintentional weight loss > 10% in the past 6 months\n* Current pregnant and lactating patients. Must have completed lactation prior to study start\n* Metastatic disease\n* Diagnosed cardiovascular disease as evidenced by cardiomyopathy (reduced regional or global LV contractility), diastolic dysfunction grade 2 or above, symptomatic coronary - artery disease, ejection fraction below 50%\n* History of prior chemotherapy or targeted H2N Treatment received less than 3 years ago\n* Non-English speaking",
    "miscellaneous_criteria": ""
}